{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:59:34Z","timestamp":1792735174340,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ejphar.2012.11.060","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T03:24:13Z","timestamp":1355282653000},"page":"101-105","source":"Crossref","is-referenced-by-count":41,"title":["The novel \u03b23-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity"],"prefix":"10.1016","volume":"699","author":[{"given":"Julie","family":"Sval\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Nordling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bouchelouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Erik","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Korstanje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bouchelouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.11.060_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/nau.20826","article-title":"Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat","volume":"29","author":"Aizawa","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2012.11.060_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eururo.2010.11.040","article-title":"Antimuscarinic mechanisms and the overactive detrusor: an update","volume":"59","author":"Andersson","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2012.11.060_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOU.0b013e32832ce8a4","article-title":"Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence","volume":"19","author":"Andersson","year":"2009","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib5","doi-asserted-by":"crossref","first-page":"820816","DOI":"10.1155\/2011\/820816","article-title":"An overview of the clinical use of antimuscarinics in the treatment of overactive bladder","volume":"2011","author":"Athanasopoulos","year":"2011","journal-title":"Adv. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.urology.2007.01.059","article-title":"Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines","volume":"69","author":"Badawi","year":"2007","journal-title":"Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1464-410X.2006.06564.x","article-title":"The effects of a new selective beta3-adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder","volume":"98","author":"Biers","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2012.11.060_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(08)60672-7","article-title":"Clinical proof of concept study (BLOSSOM) shows novel \u03b23 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder","volume":"7","author":"Chapple","year":"2008","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.ejphar.2012.11.060_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(01)05549-0","article-title":"Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function","volume":"358","author":"Drake","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2012.11.060_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.5414\/CP201782","article-title":"Single dose pharmacokinetics and absolute bioavailibility of mirabegron, a \u03b23-adrenoceptor agonist for treatment of overactive bladder.","volume":"50","author":"Eltink","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2012.11.060_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00210-007-0208-0","article-title":"Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors","volume":"377","author":"Frazier","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(01)61994-3","article-title":"Expression and possible functional role of the beta3-adrenoceptor in human and rat detrusor muscle","volume":"161","author":"Fujimura","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0702358","article-title":"Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle","volume":"126","author":"Igawa","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005392-200101000-00071","article-title":"Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders","volume":"165","author":"Igawa","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4111\/kju.2010.51.12.811","article-title":"Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder","volume":"51","author":"Igawa","year":"2010","journal-title":"Korean J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-5347(05)64634-4","article-title":"Effects of selective beta2 and beta3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats","volume":"168","author":"Kaidoh","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1523\/JNEUROSCI.3115-06.2007","article-title":"Identification of atropine- and P2\u00d71 receptor antagonist-resistant, neurogenic contractions of the urinary bladder","volume":"27","author":"Kennedy","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.11.060_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1569-9056(11)60870-1","article-title":"The efficacy and tolerability of mirabegron in patients with overactive bladder \u2014 results from a European\u2013Australian phase III trial","volume":"10","author":"Khullar","year":"2011","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.ejphar.2012.11.060_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.ju.0000067621.62736.7c","article-title":"A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders","volume":"170","author":"Nomiya","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1442-2042.2008.02165.x","article-title":"Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study","volume":"15","author":"Otsuka","year":"2008","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.11.060_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/nau.10034","article-title":"Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats","volume":"21","author":"Takeda","year":"2002","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2012.11.060_bib24","first-page":"713","article-title":"Mirabegron, a \u03b23-adrenoceptor agonist for the potential treatment of urinary frequency, urinary incontinence or urgency associated with overactive bladder","volume":"13","author":"Tyagi","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.ejphar.2012.11.060_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.phrs.2009.01.002","article-title":"The beta3-adrenoceptor as a therapeutic target: current perspectives","volume":"59","author":"Ursino","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2012.11.060_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-5347(05)65936-8","article-title":"Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat","volume":"166","author":"Woods","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2012.11.060_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0090-4295(01)01635-1","article-title":"Beta3-adrenoceptors in human detrusor muscle","volume":"59","author":"Yamaguchi","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2012.11.060_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20420","article-title":"Beta3-adrenoceptors in urinary bladder","volume":"26","author":"Yamaguchi","year":"2007","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2012.11.060_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/nau.20231","article-title":"Effects of 138-355, a beta3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro","volume":"25","author":"Yamanishi","year":"2006","journal-title":"Neurourol. Urodyn."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912009922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912009922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:04:39Z","timestamp":1540022679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912009922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0014299912009922"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.11.060","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}